louisakewell, Author at European Medical Journal - Page 61 of 153

EMJ

Phase 2a trial of ZPL-3893787 (ZPL-389), a histamine H4 receptor antagonist, for atopic dermatitis

Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, discusses the design and outcomes from a phase 2a proof-of-concept clinical trial…

Innovation in Education – EAU 2016

Don’t miss our congress review in our EMJ Urology 4.1 2016 eJournal, available now…

EMJ

Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…

EMJ

Identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies

The Oncotype DX® 21-gene Recurrence Score® result stratifies patients with breast cancer into low-, intermediate- and high-risk groups that correspond to…

EMJ

Impact of phase 3 PlanB trial on evidence-based clinical practice for breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…

EMJ

5-year outcomes from PlanB: Phase 3 trial of 21-gene Recurrence Score® result in breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…

EMJ

Overview of prospective phase 3 PlanB trial of 21-gene Recurrence Score® result in breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…

An interview with Professor Theo M. de Reijke at the 2016 EAU Congress

An interview with Professor Theo M. de Reijke (Academic Medical Center, Amsterdam, Netherlands) at the 2016 European Association of Urology Congress…

An interview with Doctor Evangelos Liatsikos at the 2016 EAU Congress

An interview with Doctor Evangelos Liatsikos (University of Patras, Patras, Greece) at the 2016 European Association of Urology Congress, Munich, Germany.

An interview with Doctor Murat Arslan at the 2016 EAU Congress

An interview with Doctor Murat Arslan (Izmir University, Izmir, Turkey) at the 2016 European Association of Urology Congress, Munich, Germany.